Aclaris Therapeutics (ACRS) Selling, General & Administrative (2014 - 2026)
Aclaris Therapeutics' Selling, General & Administrative came in at $6.05 million for Q2 2026, up 12.3% from $5.39 million a year earlier but down 10.3% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported Selling, General & Administrative of $23.24 million, up 5.0% year-over-year; for FY2025, it came in at $21.97 million, down 1.0% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 1.4% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $22.2 million in FY2024 (-31.5%), $32.41 million in FY2023 (+29.0%), $25.13 million in FY2022 (+6.4%) and $23.62 million in FY2021 (+15.0%).
- The five-year range for quarterly Selling, General & Administrative is $4.75 million (Q2 2024) to $8.79 million (Q1 2023).
- Year-over-year, Selling, General & Administrative has increased for three consecutive quarters, with an average decline of 4.5% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 54.9%), and the weakest in Q2 2024 (a decline of 42.9%).
- Business Quant data shows ACRS's Selling, General & Administrative at $6.74 million (Q1 2026), $5.58 million (Q4 2025) and $4.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Aclaris Therapeutics | 613.83 Mn | 613.83 Mn | 1.41 Mn | 6.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.05 Mn |
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 5.58 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 5.39 Mn |
| Mar 31, 2025 | 6.14 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 5.65 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | 6.84 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Sep 30, 2023 | 7.09 Mn |
| Jun 30, 2023 | 8.32 Mn |
| Mar 31, 2023 | 8.79 Mn |
| Dec 31, 2022 | 7.15 Mn |
| Sep 30, 2022 | 5.81 Mn |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 6.10 Mn |
| Dec 31, 2021 | 6.94 Mn |
| Sep 30, 2021 | 5.98 Mn |
API Access
Aclaris Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();